Boliden: Q3 Interim Report 2020
BOLIDEN, Sweden, Oct. 28, 2020 /PRNewswire/ --
Q3 2020
- Revenues totaled SEK 13,550 m (11,170)
- The operating profit totaled SEK 2,622 m (1,873)
- The operating profit, excluding revaluation of process inventory, totaled SEK 2,258 m (1,635)
- Free cash flow totaled SEK 1,878 m (-653)
- Earnings per share totaled SEK 7.44 (5.14)
Improved earnings
- Garpenberg and Kevitsa achieve new production rates following completed investments.
- The quarter's maintenance shutdowns were successfully completed despite the Covid-19 pandemic.
Please find enclosed the full report.
The Interim Report will be presented via a webcast/conference call on Wednesday,
October 28 at 09:30 (CET). Information is available at www.boliden.com.
Contact persons for information:
Mikael Staffas, President & CEO | Tel:+46 8 610 15 00 |
Håkan Gabrielsson, CFO | Tel:+46 8 610 15 00 |
Olof Grenmark, Director Investor Relations | Tel:+46 70 291 57 80 |
This information is information that Boliden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of Director Investor Relations, at 07.45 CET on October 28, 2020.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/boliden/r/q3-interim-report-2020,c3226634
The following files are available for download:
The full report (PDF) |
View original content:http://www.prnewswire.com/news-releases/boliden-q3-interim-report-2020-301161421.html
SOURCE Boliden
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Beverly Hills Plastic Surgeon Dr. Jay Calvert Named Among America's Best Plastic Surgeons 2026 by Newsweek
- NUH RECOGNISED AMONG WORLD'S GREENEST HOSPITALS; ONLY SINGAPORE HOSPITAL AWARDED HIGHEST DISTINCTION
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share